Fertility Cell Treatment - Patient Information Portal

The Science and the Treatment

The Science behind Fertility Cell Treatment

Fertility Cell Treatment is a process to mediate and expand certain types of progenitor cells found in the blood of females. This process helps mediate the secretion of paracrine growth factors and cytokines such as VEGF, IL-8, and angiopoietin, which act by binding to a multitude of receptors that span the cell membrane in the ovaries. High levels of these factors are secreted from the progenitor cells, facilitating the beneficial effects of these cells. Furthermore, these factors attach to receptors including the VEGF receptor VEGF-R2 and the Angiopoietin receptor Tie-2, both expressed upon a substantial percentage of progenitor cells, further enhancing tissue function and effectiveness.

In addition to these capabilities, secreted factors facilitate the mobilization of additional progenitor cells and other important elements involved in the healing process of damaged tissue. The potent combination of these varied beneficial capabilities makes Fertility Cell Treatment a powerful new treatment for fertility disorders.


It is important to emphasize that Fertility Cell Treatment is an autologous adult cell therapy, meaning that the cells are harvested from the patient’s own blood, thus increasing product safety by eliminating the risk of immune incompatibility. Furthermore, this therapy does not contain any animal-derived factors and cloning is not used during the manufacturing process. 




Medical professionals at the various clinics have been trained to perform all procedures. Each procedure starts at the clinic with a medical examination. Then, in a process similar to donating blood, blood is drawn and couriered to our lab under strictly controlled conditions. Because there are far too few progenitor cells in anyone's blood to be sufficiently effective, the Lab developed a proprietary technology to selectively increase the miniscule number of progenitor cells harvested from the patient's blood and turn them into millions of cells. This takes about a week. When your cells are returned from the lab, a gynecologist injects the cells into an intravenous (IV) bag of normal saline. The cells are then returned in one hour, using a normal saline Intravenous Drip. Once in the blood stream, these cells now have the potential to signal Oocyte maturation in the ovary. Within a month or two, the patient should experience an increase in Oocyte production and maturation. 


Website Builder